相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Human Endogenous Retroviruses in Glioblastoma Multiforme
Zihao Yuan et al.
MICROORGANISMS (2021)
Human APOBEC3 Variations and Viral Infection
Shiva Sadeghpour et al.
VIRUSES-BASEL (2021)
RNA sequencing for research and diagnostics in clinical oncology
Anton Buzdin et al.
SEMINARS IN CANCER BIOLOGY (2020)
The Pyrimidine Analog FNC Potently Inhibits the Replication of Multiple Enteroviruses
Na Xu et al.
JOURNAL OF VIROLOGY (2020)
A Randomized, Open-Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID-19, a Pilot Study
Zhigang Ren et al.
ADVANCED SCIENCE (2020)
Mechanistic Insight into Antiretroviral Potency of 2′-Deoxy-2′-β-fluoro-4′-azidocytidine (FNC) with a Long-Lasting Effect on HIV-1 Prevention
Li Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Integrating evolutionary dynamics into cancer therapy
Robert A. Gatenby et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Endogenous retroviruses are a source of enhancers with oncogenic potential in acute myeloid leukaemia
Ozgen Deniz et al.
NATURE COMMUNICATIONS (2020)
Promising member of the short interspersed nuclear elements (Alu elements): mechanisms and clinical applications in human cancers
Yun Jiang et al.
JOURNAL OF MEDICAL GENETICS (2019)
The HERV-K accessory protein Np9 controls viability and migration of teratocarcinoma cells
Susana M. Chan et al.
PLOS ONE (2019)
The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation
Xi Jin et al.
SCIENCE ADVANCES (2019)
Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma
Kyle T. Siebenthall et al.
EBIOMEDICINE (2019)
Close to the Bedside: A Systematic Review of Endogenous Retroviruses and Their Impact in Oncology
David F. Grabski et al.
JOURNAL OF SURGICAL RESEARCH (2019)
Retroelement-Linked H3K4me1 Histone Tags Uncover Regulatory Evolution Trends of Gene Enhancers and Feature Quickly Evolving Molecular Processes in Human Physiology
Daniil Nikitin et al.
CELLS (2019)
The Concomitant Expression of Human Endogenous Retroviruses and Embryonic Genes in Cancer Cells under Microenvironmental Changes is a Potential Target for Antiretroviral Drugs
Alessandro Giovinazzo et al.
CANCER MICROENVIRONMENT (2019)
Alternative tumour-specific antigens
Christof C. Smith et al.
NATURE REVIEWS CANCER (2019)
HERVs New Role in Cancer: From Accused Perpetrators to Cheerful Protectors
Norbert Bannert et al.
FRONTIERS IN MICROBIOLOGY (2018)
Human Endogenous Retrovirus K in the Crosstalk Between Cancer Cells Microenvironment and Plasticity: A New Perspective for Combination Therapy
Emanuele Balestrieri et al.
FRONTIERS IN MICROBIOLOGY (2018)
Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma
Anshuman Panda et al.
JCI INSIGHT (2018)
Does HERV-K represent a potential therapeutic target for prostate cancer?
Wolfgang A. Schulz
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
HERV-K activation is strictly required to sustain CD133+melanoma cells with stemness features
Ayele Argaw-Denboba et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Mobile DNA in Health and Disease
Haig H. Kazazian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Making a virtue of necessity: the pleiotropic role of human endogenous retroviruses in cancer
George Kassiotis et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
The Role of Somatic L1 Retrotransposition in Human Cancers
Emma C. Scott et al.
VIRUSES-BASEL (2017)
A human endogenous retrovirus-derived gene that can contribute to oncogenesis by activating the ERK pathway and inducing migration and invasion
Cecile Lemaitre et al.
PLOS PATHOGENS (2017)
Friends-Enemies:Endogenous Retroviruses Are Major Transriptional Regulators of Human DNA
Anton A. Buzdin et al.
FRONTIERS IN CHEMISTRY (2017)
Analysis of the Expression of Repetitive DNA Elements in Osteosarcoma
Xuan D. Ho et al.
FRONTIERS IN GENETICS (2017)
FNC efficiently inhibits mantle cell lymphoma growth
Yan Zhang et al.
PLOS ONE (2017)
A hot L1 retrotransposon evades somatic repression and initiates human colorectal cancer
Emma C. Scott et al.
GENOME RESEARCH (2016)
New bioinformatic tool for quick identification of functionally relevant endogenous retroviral inserts in human genome
Andrew Garazha et al.
CELL CYCLE (2015)
Molecular functions of human endogenous retroviruses in health and disease
Maria Suntsova et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Synthesis and Biological Evaluation of 4-Substituted Fluoronucleoside Analogs for the Treatment of Hepatitis B Virus Infection
Qinghua Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Studies of the interaction between FNC and human hemoglobin: A spectroscopic analysis and molecular docking
Huiyi Li et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2015)
FNC, a Novel Nucleoside Analogue, Blocks Invasion of Aggressive Non-Hodgkin Lymphoma Cell Lines Via Inhibition of the Wnt/β-Catenin Signaling Pathway
Yan Zhang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Azvudine, A Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-Resistant Strains than Lamivudine In Vitro
Rui-Rui Wang et al.
PLOS ONE (2014)
LINE-1 Retrotransposable Element DNA Accumulates in HIV-1-Infected Cells
R. Brad Jones et al.
JOURNAL OF VIROLOGY (2013)
Synthesis of Novel Nucleoside Analogue Phosphorothioamidate Prodrugs and in vitro Anticancer Evaluation Against RKO Human Colon Carcinoma Cells
Wei Liu et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2013)
Anti-hepatitis B virus activities of α-DDB-FNC, a novel nucleoside-biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice
Qinghua Yang et al.
ANTIVIRAL RESEARCH (2012)
Novel nucleoside analogue FNC is effective against both wild-type and lamivudine-resistant HBV clinical isolates
Yubing Zhou et al.
ANTIVIRAL THERAPY (2012)
Antiviral activity of FNC, 2′-deoxy-2′-β-fluoro-4′-azidocytidine, against human and duck HBV replication
Liyun Zheng et al.
ANTIVIRAL THERAPY (2012)
Active human retrotransposons: variation and disease
Dustin C. Hancks et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2012)
FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cells
Qiang Wang et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Synthesis and anti-HIV activity of 2′-deoxy-2′-fluoro-4′-C-ethynyl nucleoside analogs
Qiang Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
The Design, Synthesis, and Antiviral Activity of 4′-Azidocytidine Analogues against Hepatitis C Virus Replication: The Discovery of 4′-Azidoarabinocytidine
David B. Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
The Design, Synthesis, and Antiviral Activity of Monofluoro and Difluoro Analogues of 4′-Azidocytidine against Hepatitis C Virus Replication: The Discovery of 4′-Azido-2′-deoxy-2′-fluorocytidine and 4′-Azido-2′-dideoxy-2′,2′-difluorocytidine
David B. Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
2′-deoxy-4′-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2′-α-hydroxyl groups
Klaus Klumpp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Recently mobilized Transposons in the human and chimpanzee Genomes
RE Mills et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)